A glimpse of the genetics of young‐onset Parkinson’s disease in Central Asia

Molecular Genetics & Genomic Medicine

Chingiz Shashkin¹  Zhanybek Myrzayev¹  David Murphy²  Akbota Aitkulova³  Talgat Khaibullin⁴  Nazira Zharkinbekova⁵  Vadim Akhmetzhanov⁵  Malgorzata Murray⁶  Rauan Kaiyrzhanov⁶  Henry Houlden⁶  Jana Vandrovcova⁶  John Hardy⁶  Gulnaz Kaishibayeva⁷  Altynay Karimova⁸ 

[1] Contemporary Neurology and Neurorehabilitation Clinic "Shashkin Clinic", Almaty, Kazakhstan;Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK;Department of Molecular Genetics, National Center for Biotechnology, Nur‐Sultan, Kazakhstan;Department of Neurology, Semey Medical University, Semey, Kazakhstan;Department of Neurology, South Kazakhstan Medical Academy, Shymkent, Kazakhstan;Department of Neuromuscular Disorders, Institute of Neurology, University College London, London, UK;Institute of Neurology and Neurorehabilitation Named After Smagul Kaishibayev, Almaty, Kazakhstan;Kazakh Medical University of Continuing Study, Almaty, Kazakhstan;

关键词: age of onset;    Central Asia;    genetics;    Kazakhstan;    LRRK2;    Parkinson's disease;    Parkinson's disease genetics;    young‐onset;   

DOI  :  10.1002/mgg3.1671

来源: Wiley

【 授权许可】

CC BY